Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLetter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' reply.AuthorsWong, G. L.‐H.; Wong, V. W.‐S.AbstractA response from the authors of the article "Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma" in the 2016 issue is presented.SubjectsHEPATITIS B treatment; LIVER cancerPublicationAlimentary Pharmacology & Therapeutics, 2016, Vol 44, Issue 8, p910ISSN0269-2813Publication typeArticleDOI10.1111/apt.13778